Contineum Therapeutics appoints Timothy Watkins as Chief Medical Officer

Contineum Therapeutics ( NASDAQ: CTNM ), announced on Monday the appointment of Timothy Watkins, to the company’s executive team as its Chief Medical Officer and Head of Development. Effective immediately, Watkins will lead all clinical development and medical affairs activities at Contineum. Watkins succeeds Stephen.